Walleye Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,138
| Closed | -$600K | – | 1976 |
|
|
2025
Q1 | $600K | Buy |
44,138
+19,318
| +78% | +$263K | ﹤0.01% | 1007 |
|
|
2024
Q4 | $506K | Buy |
+24,820
| New | +$506K | ﹤0.01% | 1156 |
|
|
2024
Q1 | – | Sell |
-16,728
| Closed | -$359K | – | 2707 |
|
|
2023
Q4 | $359K | Buy |
+16,728
| New | +$359K | ﹤0.01% | 1288 |
|
|
2022
Q2 | – | Sell |
-28,296
| Closed | -$910K | – | 2397 |
|
|
2022
Q1 | $910K | Buy |
+28,296
| New | +$910K | 0.02% | 660 |
|
|
2021
Q1 | – | Sell |
-7,398
| Closed | -$620 | – | 1201 |
|
|
2020
Q4 | $620 | Buy |
+7,398
| New | +$620 | 0.04% | 401 |
|